Termination of Research Program. Upon not later than [ * ] prior notice Taisho may terminate the Research Program at the end of the fifth (5th) year of the Research Program if it shall be dissatisfied, in its sole judgment, with the progress or results of the Research Program. The Research Committee may terminate the Research Program any time if it determines the Research Program is no longer scientifically useful. In case of such an early termination by Taisho or the Research Committee, Taisho shall be exempt from any payment(s) that would have become due and payable after such early termination date.
Termination of Research Program. (a) The Research Program may be terminated by a Party for the material breach by the other Party of obligations under the Research Program by giving the breaching party notice of the breach and of the intent of the non-breaching Party to terminate the Research Program unless the breach is cured within ninety (90) days of notification. The non-breaching Party may terminate the Research Program following such ninety (90) day period by providing the breaching party with ninety (90) days' prior written notice that the Research Program is terminated, and the Research Program shall be terminated on the 90th day following such date.
Termination of Research Program. Genentech may terminate the Research Program for a particular Exclusive Target, with or without cause, in accordance with Section 13.4 as a termination of this Agreement pursuant to Section 13.4 with respect to such Exclusive Target at any time, subject to Sections 2.6 and 13.5 below, as applicable.
Termination of Research Program. After the third anniversary of the Effective Date, the Term of the Research Program may be terminated by Warner upon six (6) months prior written notice, subject to the following conditions:
Termination of Research Program. If Warner terminates the Research Program pursuant to Section 2.4.2 and no IND has been filed with respect to any Product Configuration prior to the date of Warner's notice of its intent to terminate the Research Program, the Agreement shall terminate concurrently with the termination of the Research Program.
Termination of Research Program. (a) Upon expiration of the Research Term or termination of the Research Program in its entirety (i) UBC and AlCana will promptly deliver to Alnylam any Program Materials and Program Technology in their possession or control and will promptly disclose, in writing, to Alnylam all Program Developments made through expiration or termination, (ii) UBC and AlCana will also submit to Alnylam a comprehensive final report within [**] days after completion (or any such termination) of the Research Program detailing the status of the Research Program and all Program Developments made thereunder as well as all Research Program funds expended, (iii) UBC and AlCana will promptly refund to Alnylam any Research Program funds remaining at the time of termination or expiration (less any non-cancelable commitments made by UBC or AlCana pursuant to the Workplan and Budget), (iv) each Party will, at the owner’s discretion, either return to each other Party or destroy all of such other Party’s Background Materials and Background Technology provided under this Agreement, and (v) the licenses granted under Article 6 shall terminate; provided, however, that clauses (i) and (ii) shall not apply in the event of any termination under Sections 10.2.2 or 10.4.4.
Termination of Research Program. If, during the Research Program Term, Symyx shall have materially breached or defaulted in the performance of any of its material obligations hereunder, and such breach or default shall have continued for sixty (60) days after written notice thereof was provided to Symyx, Bayer may, in its discretion, choose to either (i) terminate the Agreement or (ii) upon written notice to Symyx, terminate the Research Program without terminating the Agreement. Any such termination of the Agreement or the Research Program shall become effective at the end of such sixty (60) day period unless Symyx (or any other party on its behalf) has cured any such breach or default prior to the expiration of the sixty (60) day period. In the event Bayer terminates the Research Program and not the Agreement, as set forth in this section 13.2.2, Bayer shall not be obligated to pay the Research Expenses as set forth in Sections 6.1 and 6.2 for research conducted after such termination. It is understood that among other things, termination of the Research Program without termination of the Agreement, as set forth in this Section 13.2.2 shall not constitute termination of the licenses set forth in Article 5 or the payment obligations set forth in Article 6 (other than Research Expenses); provided, however, "Program Technology" shall not include any Patent Rights or Know-How or other inventions, discoveries, data, or information, or intellectual property rights in and to such inventions, discoveries, data, or information made, conceived, reduced to practice, or otherwise developed solely or jointly by Symyx, after termination of the Research Program.
Termination of Research Program. In the event that (i) Becton Dickxxxxx xxxcts to terminate the Research Program pursuant to Section 2.8(a) or (ii) the Joint Steering Committee fails to approve a Marker Validation Project Proposal, if any, provided by Becton Dickxxxxx xxxsuant to Section 2.8(b), then the Research Program shall terminate. This Agreement, including all terms, provisions, representations, rights and obligations set forth herein that do not relate to the Research Program, shall survive any termination of the Research Program pursuant to this Section 2.8.
Termination of Research Program. If, during the Research Program Term, Symyx shall have materially breached or defaulted in the performance of any of its material obligations hereunder, and such breach or default shall have continued for sixty (60) days after written notice thereof was provided to Symyx, Bayer may, in its discretion, choose to either (i) terminate the Agreement or (ii) upon written notice to Symyx, terminate the Research Program without terminating the Agreement. Any such termination of the Agreement or the Research Program shall become effective at the end of such sixty (60) day period unless Symyx (or any other party on its behalf) has cured any such breach or default prior to the expiration of the sixty (60) day period. In the event Bayer terminates the Research Program and not the Agreement, as set forth in this section 13.2.2, Bayer shall not be obligated to pay the Research Expenses as set forth in Sections 6.1 and 6.2 for research conducted after such termination. It is understood that among other things, termination of the Research Program without termination of the Agreement, as set forth in this Section 13.2.2 shall not constitute termination of the licenses set forth in
Termination of Research Program. The Research Program and the Research Plan shall automatically terminate on the effective date of any termination of this Agreement pursuant to Section 11.2 or 11.3. In addition, Pfizer may terminate the Research Program and the Research Plan if Incyte has materially breached its obligations under Article 3 of this Agreement or under the Research Plan, such termination to be effective thirty (30) days after Incyte’s receipt of a notice from Pfizer to such effect in accordance with Section 15.3; provided that if Incyte has cured such breach prior to the expiration of such thirty (30)-day period, then the Research Program and Research Plan shall remain in effect pursuant to the terms thereof. As a result of any termination in accordance with this Section 3.6, Article 2 (other than Sections 2.4(f) and 2.4(g)), Article 3, the Research Program and the Research Plan shall cease to be in effect and neither Party shall have any further obligations with respect thereto.
